Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BIRC2 | Q13490 | 1/20 | 0.60 |
| ▸ | CTSK | P43235 | 4/20 | 0.58 |
| ▸ | CTSS | P25774 | 3/20 | 0.58 |
| ▸ | CTSL | P07711 | 1/20 | 0.58 |
| ▸ | CTSB | P07858 | 1/20 | 0.58 |
| ▸ | REN | P00797 | 2/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.56 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.55 |
| ▸ | MMP2 | P08253 | 7/20 | 0.53 |
| ▸ | MMP1 | P03956 | 2/20 | 0.53 |
| ▸ | MMP3 | P08254 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22962429 | 0.97 | REN (0.61) | BIRC2CTSKCTSSCTSLCTSB | |
| SCHEMBL24345963 | 0.95 | BIRC2 (0.62) | BIRC2CTSKCTSSCTSLCTSB | |
| SCHEMBL29498132 | 0.93 | REN (0.61) | BIRC2CTSKCTSSCTSLCTSB | |
| SCHEMBL12890830 | 0.93 | REN (0.61) | BIRC2CTSKCTSSCTSLCTSB | |
| SCHEMBL29651542 | 0.92 | REN (0.57) | BIRC2CTSKCTSSCTSLCTSB | |
| SCHEMBL20030598 | 0.89 | CTSS (0.68) | CTSKCTSSCTSLCTSBREN | |
| SCHEMBL17138017 | 0.89 | CTSS (0.68) | CTSKCTSSCTSLCTSBREN | |
| SCHEMBL30135036 | 0.89 | CTSS (0.68) | CTSKCTSSCTSLCTSBREN | |
| SCHEMBL17138015 | 0.89 | CTSS (0.68) | CTSKCTSSCTSLCTSBREN | |
| SCHEMBL27507036 | 0.89 | CTSS (0.68) | CTSKCTSSCTSLCTSBREN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210040150-A1 | KAPPA OPIOID RECEPTOR PEPTIDE AMIDE AGONISTS | YICHANG HUMANWELL PHARMACEUTICALS CO., LTD. (CN) | 2021-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210040150-A1 | KAPPA OPIOID RECEPTOR PEPTIDE AMIDE AGONISTS | OPRK1, OPRL1, OPRD1 | BIRC2 4337/4885CTSK 1207/4885CTSS 2439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.